(ALNY) |
| 0 (0%) 10-10 11:47 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 484.21 |
| Resistance 1: | 468.28 |
| Pivot price: | 454.97 |
| Support 1: | 442.51 |
| Support 2: | 368.17 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -2.490 |
| Book Value | 1.910 |
| PEG Ratio | 0.00 |
| Gross Profit | 15.716 |
| Profit Margin (%) | -12.96 |
| Operating Margin (%) | -2.09 |
| Return on Assets (ttm) | -2.6 |
| Return on Equity (ttm) | -257.8 |
Company news
Fri, 10 Oct 2025
ALNY: HC Wainwright & Co. Reiterates Buy Rating with $570 Price Target | ALNY Stock News - GuruFocus
Fri, 10 Oct 2025
Building trade automation scripts for ALNY - 2025 Key Lessons & Weekly Top Gainers Alerts - newser.com
Thu, 09 Oct 2025
Shell Asset Management Co. Purchases 1,602 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Wed, 08 Oct 2025
Weiss Ratings Reaffirms "Sell (D-)" Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY) - MarketBeat
Mon, 06 Oct 2025
Did Amvuttra’s Phase 3 Update and ZENITH Trial Milestone Just Shift Alnylam’s (ALNY) Investment Narrative? - simplywall.st
Mon, 06 Oct 2025
Alnylam Pharmaceuticals (ALNY) Gets Target Price Boost from Morgan Stanley | ALNY Stock News - GuruFocus
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
